A draft proposal clarifying CBD regulations in France could lead to further enforcement on the sales of CBD products – heavily impacting the current make-up of the French market in the process. The draft arrêté, not publicly available but seen by CBD-Intel, would clarify current unclear regulations for CBD including unequivocally banning hemp flowers as a product. This would severely » Continue Reading.
This regulatory report looks at the current situation for CBD in Austria, focusing on cultivation, processing, import and export, extracts and finished products
Mississippi supporters of medical cannabis are fighting to have their voices heard after a vote for legalisation was thrown out by the US state’s Supreme Court
Hemp flowers are treated similarly in Europe to all other hemp-derived CBD products in that market restrictions differ from country to country
This week’s regulatory news in brief includes updates from Ireland, Italy, Portugal, Spain, Ukraine, the US, Argentina and Colombia
A new UK cannabis industry association claims to be the first to bring together members from every aspect of the industry – with a range of more than 100 members already
This report provides an overview of the current regulations for import and export of hemp, cannabis and CBD products in China
This report examines which US states that have legalised medical or recreational cannabis allow for the sale of hemp-derived CBD products in their dispensaries
This week’s regulatory news in brief includes updates from Belgium, France, Denmark, Germany, Greece, Italy, Luxembourg, the US, China and Morocco
Despite the island state’s generally liberal outlook, and long association with cannabis culture, legalisation of recreational use remains a frustrated dream for many in Hawaii
Significant changes are not expected for Spanish CBD and cannabis regulation in the short term as the main political parties remain conservative. This report provides an overview of the current status of CBD, hemp and cannabis
Early moves towards a regulatory framework that would allow a cannabinoid industry in Argentina have been welcomed by insiders who hope ultimately to match or surpass the progress made by other South American nations
This report offers an overview of the current regulatory regime in Bulgaria for CBD, hemp and cannabis, covering all areas from cultivation and processing to finished products, and medical and recreational cannabis
This week’s regulatory news in brief includes updates from EU, France, Germany, Greece, Ireland, Lithuania, Switzerland, UK, US, Argentina, Australia, Brazil, Ecuador, Morocco and South Africa
Because US states can and do differ from federal law when it comes to controlled substances, it is important to analyse each state’s law on delta-8 THC. This report provides a state-by-state guide to delta-8 THC
CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses multiple parts including cannabinoids, derivatives and isomers and shields them from the federal definition of tetrahydrocannabinols listed in Schedule I of the » Continue Reading.
Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold
CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows how cosmetics now have more exposure to the wider population by having a more diverse range of brand offerings along with greater » Continue Reading.
This week’s regulatory news in brief includes updates from Austria, Germany, Greece, Malta, Spain, the UK, the US, China, Japan, New Zealand, Panama and Uruguay
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as well as discussion around how » Continue Reading.
This report offers an in-depth look at the current regulatory framework for hemp, CBD and cannabis in the UK, including its medical and recreational cannabis regime
This week’s regulatory news in brief includes updates from the EU, France, Greece, Lithuania, Poland, Portugal, Serbia, Spain, Switzerland, UK, Canada, Mexico, US, Australia and China
Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must retain, and prepare to make available upon request, records establishing compliance with all applicable federal, state, and local laws pertaining to hemp » Continue Reading.
With federal elections due in September, Germany’s Free Democratic Party (FDP) has called on the government to draft a law permitting the controlled distribution of cannabis for adult use
This week’s regulatory news in brief includes updates from Belgium, Latvia Portugal, UK, US, Argentina, Armenia, Australia and Brazil
South Africa releases the National Cannabis Master Plan, which will not only boost and uplift the southern Africa cannabis industry, but will set a regional precedent for the growth of a legal cannabis market in the area
CBD will become legal for the first time in Slovakia on 1st May 2021. This report offers a detailed overview of the regulatory framework in the country for hemp, CBD and medical and recreational cannabis
This week’s regulatory news in brief includes updates from Germany, Latvia Malta, Netherlands, Poland, Spain, UK, Canada, US, China, Lesotho and Malawi
The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released
This week’s regulatory news in brief includes updates from France, Italy, Lithuania, Malta, Norway, Poland, Spain, Sweden, Ukraine and the US
Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature
It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop
Cultivation of hemp with less than 0.2% THC is legal in Denmark. This report provides an overview of the country’s regulatory framework for CBD, hemp and cannabis
This week’s regulatory news in brief includes updates from Czech Republic, Belgium, the UK, Mexico and the US
States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest
This report offers an overview of the current regulatory framework in place for hemp, CBD and cannabis in Sweden
This report provides an overview of the regulatory regime for CBD, hemp and cannabis in Taiwan
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in violation of the Food Drug & Cosmetics (FD&C) Act. But the other two represented something different. For one, they came from a new FDA » Continue Reading.
Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes
The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework
Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of intoxication
This week’s regulatory news in brief includes updates from the Cyprus. Czech Republic, the EU, Finland, France, Germany, Iceland, Malta, Switzerland, the US, and Argentina
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.
This report covers the current regulatory regime for hemp, CBD and cannabis in South Africa, including the regimes for medical and recreational cannabis
An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US
This report addresses the reasons why CBD and cannabis-related businesses in the US have trouble obtaining banking and payment processing services, what they can do, and what might be done to address the problem
This week’s regulatory news in brief includes updates from the EU, France, Germany, the UK, the US, China and Thailand
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.
Podcasts editor Jon Bruford is joined by Anthony Traurig, CBD-Intel legal analyst and US specialist, to discuss the legal and regulatory concerns that hang over cannabis in the US and Canada and the economic impact of Covid-19